Corcept Therapeutics Past Performance

How has Corcept Therapeutics performed over the past 5 years?

[object Object] Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


1.3%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CORT has high quality earnings.

Growing Profit Margin: CORT's current net profit margins (29.4%) are lower than last year (30.2%).


Past Earnings Growth Analysis

Earnings Trend: CORT's earnings have grown by 1.3% per year over the past 5 years.

Accelerating Growth: CORT's earnings growth over the past year (9.7%) exceeds its 5-year average (1.3% per year).

Earnings vs Industry: CORT earnings growth over the past year (9.7%) exceeded the Pharmaceuticals industry 8.4%.


Return on Equity

High ROE: CORT's Return on Equity (24.7%) is considered high.


Discover strong past performing companies